Search Within

GDMT, Medicine

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (73)
  2. Meeting Abstract (53)
  3. Research Letter (1)
Groups
  1. Department of Medicine (127)
  2. GSK Faculty (127)
  3. Gynecology Disease Management Team (127)
  4. Human Oncology and Pathogenesis Program (127)
  5. Solid Tumor Oncology Division (123)
  6. Gynecologic Medicine Service (118)

More Groups

People
  1. Michael Berger (58)
  2. David Solit (49)
  3. Carol Aghajanian (40)
  4. Marc Ladanyi (40)
  5. Zsofia Stadler (30)
  6. Britta Weigelt (29)

More People

Years
  1. 2025 (3)
  2. 2024 (14)
  3. 2023 (18)
  4. 2022 (21)
  5. 2021 (14)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (29)
  2. Gynecologic Oncology (10)
  3. JCO Precision Oncology (9)
  4. Clinical Cancer Research (8)
  5. Modern Pathology (8)
  6. Annals of Oncology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (39)
  2. American Association for Cancer Research (22)
  3. Elsevier Inc. (16)
  4. Nature Publishing Group (9)
  5. Nature Research (9)
  6. Oxford University Press (9)

More Publishers

Results (127)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I dose escalation study of the PI3kinase pathway inhibitor BKM120 and the oral poly (ADP ribose) polymerase (PARP) inhibitor olaparib for the treatment of high-grade serous ovarian and breast cancer
    Journal Article

    Matulonis, U. A.; Wulf, G. M.; Barry, W. T.; Birrer, M.; Westin, S. N.; Farooq, S.; Bell-McGuinn, K. M.; Obermayer, E.; Whalen, C.; Spagnoletti, T.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • OncoKB: Annotation of the oncogenic effect and treatment implications of somatic mutations in cancer
    Meeting Abstract

    Chakravarty, D.; Phillips, S. M.; Gao, J.; Kundra, R.; Zhang, H.; Rudolph, J. E.; Yaeger, R. D.; Soumerai, T.; Nissan, M. H.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Intestinal microbiota and relapse after hematopoietic-cell transplantation
    Meeting Abstract

    Peled, J.; Devlin, S.; Staffas, A.; Lumish, M.; Rodriguez, K. P.; Ahr, K.; Perales, M.; Giralt, S.; Taur, Y.; Pamer, E.; more...
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save
  • Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: Overall survival and updated progression-free survival results from a phase II study
    Journal Article

    Smyth, L. M.; Iyengar, N. M.; Chen, M. F.; Popper, S. M.; Patil, S.; Wasserheit-Lieblich, C.; Argolo, D. F.; Singh, J. C.; Chandarlapaty, S.; Sugarman, S. M.; more...
    Breast Cancer Research and Treatment (2016)

    Fulltext@MSK | Save
  • Molecular subtypes of uterine leiomyosarcoma and correlation with clinical outcome
    Journal Article

    Barlin, J. N.; Zhou, Q. C.; Leitao, M. M.; Bisogna, M.; Olvera, N.; Shih, K. K.; Jacobsen, A.; Schultz, N.; Tap, W. D.; Hensley, M. L.; more...
    NeoPlasia (2015)

    Fulltext@MSK | Save
  • Phase I of oral BKM120 or BYL719 and olaparib for high-grade serous ovarian cancer or triple-negative breast cancer: Final results of the BKM120 plus olaparib cohort
    Meeting Abstract

    Matulonis, U. A.; Wulf, G.; Barry, W.; Birrer, M.; Westin, S.; Spagnoletti, T.; Bell-McGuinn, K.; Obermayer, E.; Whalen, C.; Aghajanian, C.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Extreme outlier analysis identifies occult mitogen-activated protein kinase pathway mutations in patients with low-grade serous ovarian cancer
    Journal Article

    Grisham, R. N.; Sylvester, B. E.; Won, H.; McDermott, G.; DeLair, D.; Ramirez, R.; Yao, Z.; Shen, R. L.; Dao, F.; Bogomolniy, F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Precision medicine at Memorial Sloan Kettering Cancer Center: Clinical next-generation sequencing enabling next-generation targeted therapy trials
    Journal Article

    Hyman, D. M.; Solit, D. B.; Arcila, M. E.; Cheng, D. T.; Sabbatini, P.; Baselga, J.; Berger, M. F.; Ladanyi, M.
    Drug Discovery Today (2015)

    Fulltext@MSK | Save
  • Identifying actionable mutations in uterine leiomyosarcoma
    Meeting Abstract

    Soumerai, T.; Hyman, D. M.; Murali, R.; Zehir, A.; O'Cearbhaill, R. E.; Arcila, M. E.; Aghajanian, C.; Soslow, R. A.; Solit, D. B.; Hensley, M. L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result
    Meeting Abstract

    Smyth, L. M.; Iyengar, N. M.; Chandarlapaty, S.; Sugarman, S.; Comen, E. A.; Drullinsky, P.; Sklarin, N. T.; Traina, T. A.; Troso-Sandoval, T. A.; Patil, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save